Ana‐Matea Mikecin

433 total citations
12 papers, 147 citations indexed

About

Ana‐Matea Mikecin is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Ana‐Matea Mikecin has authored 12 papers receiving a total of 147 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Ana‐Matea Mikecin's work include RNA Interference and Gene Delivery (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and interferon and immune responses (1 paper). Ana‐Matea Mikecin is often cited by papers focused on RNA Interference and Gene Delivery (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and interferon and immune responses (1 paper). Ana‐Matea Mikecin collaborates with scholars based in Croatia, Belgium and Spain. Ana‐Matea Mikecin's co-authors include Miguel Á. Idoate, Marta Larráyoz, Jackeline Agorreta, Ivana Grbeša, Luis M. Montuenga, María J. Pajares, Elena Martínez‐Terroba, Koraljka Gall‐Trošelj, Rubén Pı́o and Dražen Raucher and has published in prestigious journals such as PLoS ONE, Annals of the New York Academy of Sciences and Tetrahedron.

In The Last Decade

Ana‐Matea Mikecin

11 papers receiving 146 citations

Peers

Ana‐Matea Mikecin
Tracy Kleinheinz United Kingdom
Natalie Roy D’Amore United States
J. Kim South Korea
Evert Njomen United States
Samantha Ferries United Kingdom
Joyce H. Lee United States
Ana‐Matea Mikecin
Citations per year, relative to Ana‐Matea Mikecin Ana‐Matea Mikecin (= 1×) peers Peiqiang Yan

Countries citing papers authored by Ana‐Matea Mikecin

Since Specialization
Citations

This map shows the geographic impact of Ana‐Matea Mikecin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana‐Matea Mikecin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana‐Matea Mikecin more than expected).

Fields of papers citing papers by Ana‐Matea Mikecin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana‐Matea Mikecin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana‐Matea Mikecin. The network helps show where Ana‐Matea Mikecin may publish in the future.

Co-authorship network of co-authors of Ana‐Matea Mikecin

This figure shows the co-authorship network connecting the top 25 collaborators of Ana‐Matea Mikecin. A scholar is included among the top collaborators of Ana‐Matea Mikecin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana‐Matea Mikecin. Ana‐Matea Mikecin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Šarić, Ana, Sandra Sobočanec, Ana‐Matea Mikecin, et al.. (2017). TORC 1‐mediated sensing of chaperone activity alters glucose metabolism and extends lifespan. Aging Cell. 16(5). 994–1005. 18 indexed citations
2.
Šarić, Ana, Ivo Crnolatac, Frédéric Bouillaud, et al.. (2017). Non-toxic fluorescent phosphonium probes to detect mitochondrial potential. Methods and Applications in Fluorescence. 5(1). 15007–15007. 13 indexed citations
3.
Mikecin, Ana‐Matea, et al.. (2016). Salinomycin affects Golgi apparatus function in cancer stem-like cells. European Journal of Cancer. 61. S113–S113. 1 indexed citations
4.
Ladouce, Romain, Ana‐Matea Mikecin, Fernando A. Martín, et al.. (2015). Death by UVC Light Correlates with Protein Damage in Isogenic Human Tumor Cells: Primary Tumor SW480 versus its Metastasis SW620. Institutional Repository of the Ruđer Bošković Institute (Ruđer Bošković Institute). 2(1). 1–12. 2 indexed citations
5.
Grbeša, Ivana, María J. Pajares, Elena Martínez‐Terroba, et al.. (2015). Expression of Sirtuin 1 and 2 Is Associated with Poor Prognosis in Non-Small Cell Lung Cancer Patients. PLoS ONE. 10(4). e0124670–e0124670. 64 indexed citations
6.
Vazdar, Mario, Marijana Đaković, Ana‐Matea Mikecin, et al.. (2015). Synthesis of new 2-aminoimidazolones with antiproliferative activity via base promoted amino-β-lactam rearrangement. Tetrahedron. 71(49). 9202–9215. 10 indexed citations
7.
Mikecin, Ana‐Matea, et al.. (2013). Thermally targeted p21 peptide enhances bortezomib cytotoxicity in androgen-independent prostate cancer cell lines. Anti-Cancer Drugs. 25(2). 189–199. 14 indexed citations
8.
Kukovec, Boris‐Marko, et al.. (2013). Preparation and characterization of palladium(II) complexes with N-arylalkyliminodiacetic acids. Catalytic activity of complexes in methoxycarbonylation of iodobenzene. Journal of Organometallic Chemistry. 760. 224–230. 9 indexed citations
9.
Rajić, Zrinka, Ana‐Matea Mikecin, Marijeta Kralj, et al.. (2012). New Sorafenib Derivatives: Synthesis, Antiproliferative Activity Against Tumour Cell Lines and Antimetabolic Evaluation. Molecules. 17(1). 1124–1137. 13 indexed citations
10.
Grdiša, M. & Ana‐Matea Mikecin. (2008). Drug Delivery by TAT-technology. Institutional Repository of the Ruđer Bošković Institute (Ruđer Bošković Institute). 2 indexed citations
11.
Grdiša, Mira & Ana‐Matea Mikecin. (2008). ChemInform Abstract: Drug Delivery by TAT‐Technology. ChemInform. 39(41). 1 indexed citations
12.
Grdiša, Mira, et al.. (2006). Does Transduced p27 Induce Apoptosis in Human Tumor Cell Lines?. Annals of the New York Academy of Sciences. 1090(1). 120–129.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026